Diego Pasini Selected Research

Proteins (Proteins, Gene)

1/2020	Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype.
10/2016	Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice.
1/2016	Emerging roles for Polycomb proteins in cancer.
1/2016	Mapping the Function of Polycomb Proteins.
5/2015	The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins?
4/2014	Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication.
1/2011	Epigenetic factors in cancer development: polycomb group proteins.
7/2008	The polycomb repressive complex 2 is a potential target of SUMO modifications.
6/2007	Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.
5/2006	Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Pasini Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 04/2004
3	Carcinogenesis 01/2022 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 01/2017
2	Leukemia 10/2016 - 06/2007
1	Inflammation (Inflammations) 10/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2020
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Laminopathies 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Residual Neoplasm 01/2020
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Pathologic Neovascularization 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 03/2015
1	Acute Promyelocytic Leukemia 06/2007
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2005
1	Breast Neoplasms (Breast Cancer) 07/2004

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2004
4	Polycomb-Group ProteinsIBA 05/2015 - 04/2004
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2012
2	CateninsIBA 10/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 12/2018 - 07/2004
2	ChromatinIBA 01/2011 - 05/2006
2	Polycomb Repressive Complex 2IBA 06/2007 - 04/2004
1	Histones (Histone)IBA 01/2022
1	LipopolysaccharidesIBA 10/2021
1	Cre recombinaseIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	AntibodiesIBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	LigandsIBA 01/2020
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2020
1	Lamin Type A (Lamin A)IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2018
1	tyrosine receptor (receptor, tyrosine)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Claudin-5IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017
1	Long Noncoding RNAIBA 03/2015
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 06/2007
1	E2F Transcription FactorsIBA 04/2005
1	RNA (Ribonucleic Acid)IBA 07/2004
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 07/2004

Therapy/Procedure

2	Therapeutics 12/2018 - 07/2004
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020